Alerts will be sent to your verified email
Verify EmailAUROPHARMA
Balance sheet of Aurobindo Pharma is strong.
It shouldn't have solvency or liquidity issues.
Yes, The net debt of Aurobindo Pharma is increasing.
Latest net debt of Aurobindo Pharma is -₹293.81 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹6,241.12 Crs.
Yes, profit is increasing.
The profit of Aurobindo Pharma is ₹3,515 Crs for TTM, ₹3,173 Crs for Mar 2024 and ₹1,928 Crs for Mar 2023.
The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aurobindo Pharma latest dividend payout ratio is 8.31% and 3yr average dividend payout ratio is 12.45%
Companies resources are allocated to majorly productive assets like Plant & Machinery